Genomic data with clinical outcome data from routine practice data from Dana-Farber Cancer Institute, Boston, MA, USA
Initiatives
-
To answer questions about new cancer therapies, including: what diseases should they be used for? What doses of new drugs are most effective? And which patients can benefit the most from them?
Visit DFCI
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Patients' cohort
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |